Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (151-160 of 294) with videos related to

Pageof 30
Sort By:
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseasesArik Bernard Schulze, Georg Evers, Andreas Kümmel, et al.
Frontiers in Oncology|August 25, 2022
Presence of the <i>GFI1-36N</i> single nucleotide polymorphism enhances the response of <i>MLL-AF9</i> leukemic cells to CDK4/6 inhibitionJan Vorwerk, Kaiyan Sun, Daria Frank, et al.
Nature Immunology|March 27, 2019
Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophilsJosephine Fischer, Carolin Walter, Alexander Tönges, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2023
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasionCorinna Kosnopfel, Simone Wendlinger, Heike Niessner, et al.
Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.
Frontiers in Cell and Developmental Biology|April 24, 2023
Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCsXiaoqing Xie, Pradeep Kumar Patnana, Daria Frank, et al.
Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Genes & Development|October 8, 2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsHua Jing, Julia Kase, Jan R Dörr, et al.
Pageof 30

Showing results (151-160 of 294) with videos related to

Sort By:
Pageof 30
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseasesArik Bernard Schulze, Georg Evers, Andreas Kümmel, et al.
Frontiers in Oncology|August 25, 2022
Presence of the <i>GFI1-36N</i> single nucleotide polymorphism enhances the response of <i>MLL-AF9</i> leukemic cells to CDK4/6 inhibitionJan Vorwerk, Kaiyan Sun, Daria Frank, et al.
Nature Immunology|March 27, 2019
Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophilsJosephine Fischer, Carolin Walter, Alexander Tönges, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2023
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasionCorinna Kosnopfel, Simone Wendlinger, Heike Niessner, et al.
Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.
Frontiers in Cell and Developmental Biology|April 24, 2023
Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCsXiaoqing Xie, Pradeep Kumar Patnana, Daria Frank, et al.
Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
Genes & Development|October 8, 2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsHua Jing, Julia Kase, Jan R Dörr, et al.
Pageof 30